Stem cells from human exfoliated deciduous teeth (SHED) transplants have been investigated as a possible treatment strategy for spinal cord injuries (SCI) due to their potential for promoting functional recovery. The aim of present study was to investigate the effects of SHED on neuronal death after an experimental model of SCI. Methods: Wistar rats were spinalized using NYU impactor Ò . Animals were randomly distributed into 4 groups: Control (Naive) or Surgical control, Sham (laminectomy with no SCI); SCI (laminectomy followed by SCI, treated with vehicle); SHED (SCI treated with intraspinal transplantation of 3 Â 10 5 SHED, 1 h after SCI). Functional evaluations and morphological analysis were performed to confirm the spinal injury and the benefit of SHED transplantation on behavior, tissue protection and motor neuron survival. Flow cytometry of neurons, astrocytes, macrophages/microglia and T cells of spinal cord tissue were run at six, twenty-four, forty-eight and seventy-two hours after lesion. Six hours after SCI, ELISA and Western Blot were run to assess pro-and anti-apoptotic factors. The SHED group showed a significant functional improvement in comparison to the SCI animals, as from the first week until the end of the experiment. This behavioral protection was associated with less tissue impairment and greater motor neuron preservation. SHED reduced neuronal loss over time, as well as the overexpression of pro-apoptotic factor TNF-a, while maintained basal levels of the anti-apoptotic BCL-XL six hours after lesion. Data here presented show that SHED transplantation one hour after SCI interferes with the balance between pro-and anti-apoptotic factors and reduces early neuronal apoptosis, what contributes to tissue and motor neuron preservation and hind limbs functional recovery.
Introduction
Spinal Cord Injury (SCI) leads to major deficits or complete loss of sensory-motor function and to disruption of autonomic function; and the development of a treatment for SCI is one of the major challenges in biomedical research (Lee and Thumbikat, 2015; Rowland et al., 2008; Sadowsky et al., 2002) . The primary spinal injury occurs after the physical deformation of the cord; however, a large number of neurons are lost due to a variety of pathophysiologic events that are initiated by the original mechanical insult, the secondary injury (Anderson and Hall, 1993; Lee and Thumbikat, 2015; Rowland et al., 2008; Sadowsky et al., 2002) . This secondary spinal cord injury includes necrosis (Ducker et al., 1971) , free radical formation (Anderson et al., 1985; Braughler and Hall, 1989; Kurihara, 1985) , K + accumulation in the extracellular space (Chesler et al., 1994; Young et al., 1982) , glutamatemediated excitotoxicity (Dorsett et al., 2016) , edema (Ge et al., 2013; Sharma and Olsson, 1990) , and apoptosis (Crowe et al., 1997; Liu et al., 1997) . Ninety percent of neurons are lost in the first eight hours after the spinal injury, mostly due to apoptosis (Casella et al., 2006; Lou et al., 1998 programmed cell death, as well as mitochondrial membrane disruption, what releases pro-apoptotic factors (Elmore, 2007) . On the other hand, glutamatergic excitotoxicity results in the influx of calcium and subsequent calmodulin-mediated activation of neuronal nitric oxide synthase (nNOS); this activation of nNOS may participate in the mitochondrial membrane impairment process and the consequent activation of apoptosis-related mechanisms (Blomgren et al., 2007; Zhu et al., 2004) . These events converge to the same execution pathway, beginning with the cleavage of caspase-3 followed by DNA fragmentation, degradation of cytoskeletal and nuclear proteins, cross-linking of proteins, formation of apoptotic bodies, expression of ligands for phagocytic cell receptors and finally uptake by phagocytic cells (Blomgren et al., 2007; Elmore, 2007) . All of these processes could be considered possible targets for the treatment of spinal cord injury.
Stem cells from human exfoliated deciduous teeth (SHED), found within the perivascular niche of dental pulp (Gronthos et al., 2002) , express early markers for both mesenchymal and neuroectodermal stem cells (Achilleos and Trainor, 2012; Gronthos et al., 2000; Miura et al., 2003) . It has been recently shown that engrafting SHED promotes functional recovery after spinal cord injury (De Berdt et al., 2015; Nicola et al., 2016; Sakai et al., 2012; Taghipour et al., 2012) and this effect can be partly explained by SHED anti-inflammatory action evidenced by macrophage modulation 72 h after spinal cord contusion (Matsubara et al., 2015) .
The present study was designed to verify the short-and longterm effects of SHED transplantation one hour after spinal cord contusion on neuronal survival associated with motor function recovery. The working hypothesis is that SHED transplantation would reduce acute neuronal loss probably by reducing neuronal apoptosis.
Results

Functional evaluation
Two days before, two days after and weekly until the sixth week post contusion, the behavioral assessment was conducted through the BBB Locomotor Rating Scale. All animals showed normal locomotor function in the preoperative evaluation; however, hind limb function of lesioned groups, SCI and SHED, was greatly impaired two days after the injury, as compared to the control group (Fig. 2) . In the seventh day, spontaneous motor function recovery was observed in both lesioned groups (P < 0.05, Fig. 2) . A further significant increment in hind limb function was seen in the SHED group as early as one week post lesion; such difference remained until the sixth week. Animals of the control group reached maximal scores in BBB scale in all assessments, i.e., presented normal motor function.
Tissue loss
The SCI group presented large cavity areas (0.27 ± 0.01 mm 3 ) extending along the spinal cord as assessed six weeks after contusion (Fig. 3 A) . The early injection of SHED reduced tissue loss (0.16 ± 0.02 mm 3 ) at the epicenter and 200 mm caudally to the lesion site, as revealed by lower cystic cavity volume (Fig. 3 A, B) [t(1,9) = 3.11, P < 0.05]. Interestingly, the SHED group also presented larger white matter volume (0.82 ± 0.004 mm 3 ) when compared to SCI rats (0.77 ± 0.01 mm 3 ) (Fig. 3 C) [t(1,9) = 4.09, P < 0.05]. These results indicate that this type of spinal cord injury promotes severe tissue loss that is greatly prevented by SHED treatment.
Motor neuron evaluation
Histological evaluation confirmed a reduction of motor neurons in the ventral horn of the spinal cord in the SCI group (4.15 ± 0.70 motor neurons/section) as compared to the control group (16.08 ± 0.84 motor neurons/section) assessed six weeks after lesion; the treatment with SHED was able to partly preserve the number of motor neurons (9.77 ± 0.96 motor neurons/section) ( Fig. 3 D, E) [F(2,12) = 37.54, P < 0.05]. The maintenance of motor neurons was associated with hind limbs motor recovery, as revealed by the strong Pearson's positive correlation between motor neuron number and the score of the last functional BBB section (r = 0.866, P < 0.05); this indicates that SHED partially prevented the loss of motor neurons in the ventral spinal cord and that was associated with functional recovery.
Spinal cord cell quantification by flow cytometry
Flow cytometry was run six, twenty-four, forty-eight and seventy-two hours after SCI in order to evaluate the number of Fig. 1 . Experimental design of the three experiments. The spinal cord injury was performed in two groups: SCI and SHED. The SHED group received cell administration one hour after lesion. In the first experiment, all animals were conducted to the functional evaluation forty-eight hours and weekly after SCI. Six weeks after, the animals were euthanized and samples were collected to proceed with the morphologic analyzes of cystic cavity, white matter volume and number of motor neurons in the spinal cord. In the second experiment, samples of spinal cord were collected six, twenty-four, forty-eight and seventy-two hours after lesion to perform flow cytometry of neurons, astrocytes, macrophages/microglia and T cells. At the same time points TNF-a levels were assessed. In the third experiment, samples of spinal cord were collected six hours after SCI to evaluate apoptotic neurons by flow cytometry and the expression of BCL-XL, EAAT3 and nNOS by Western Blot.
neurons, astrocytes, macrophage/microglia and T cells in spinal cord tissue. There was a loss of $25.7% of neurons in the first six hours after injury; the SCI (5.65 ± 0.34% of neurons) and SHED (6.06 ± 0.46% of neurons) groups showed significant neuronal reduction in comparison to control group (7.88 ± 0.18% of neurons) [F(2,16) = 18.51, P < 0.05]. A loss of $76% of neurons was recorded twenty-four hours after lesion, the SCI group reduced to only 1.70 ± 0.12% of neurons and SHED group to 2.00 ± 0.04% of neurons [F(2,16) = 380.47, P < 0.05]. Although SCI (1.29 ± 0.14% of neurons) rats had a further reduction of neurons after forty-eight hours the SHED group (1.84 ± 0.04% of neurons) showed a stabilization of neuronal number, being different from SCI group [F(2,16) = 407.97, P < 0.05]. Similar results were seen seventy-two hours after SCI (1.50 ± 0.23% of neurons) and SHED (2.61 ± 0.44% of neurons), with no further neuronal loss [F(2,16) = 222.54, P < 0.05]. As seen in Fig. 4A , the progressive neuronal loss that occurs at early stages was reduced by SHED transplantation.
Interestingly, there was no change in the astrocyte numbers six hours after lesion in both SCI and SHED groups (P > 0.05) (Fig. 4 B) . The number astrocytes decreases at twenty-four hours in SCI (2.82 ± 0.28% of astrocytes) and SHED (3.22 ± 0.46% of astrocytes) [F(2,18) = 28.69, P < 0.05], as well as at forty-eight hours in SCI (4.26 ± 0.58% of astrocytes) and SHED groups (4.99 ± 0.32% of astrocytes) [F(2,18) = 9.58, P < 0.05]. Interestingly, SCI caused an increase of astrocytes measured seventy-two hours after injury (12.76 ± 1.11% of astrocytes). The number of astrocytes in the SHED group was kept in basal values (9.12 ± 1.33% of astrocytes) when compared to controls at this time point [F(2,16) = 4.98, P < 0.05], suggesting that SHED was able to prevent astrocyte hyperplasia in the parenchyma of spinal cord seventy-two hours after contusion.
Measurements of macrophage/microglia, as well as of T cells were performed to evaluate the immune response (Fig. 4 C) . In the first twenty-four hours, there was a reduction of macrophage/microglia cells in the spinal cord in both spinalized groups, SCI (1.88 ± 0.11% of macrophage/microglia) and SHED (2.06 ± 0.25% of macrophage/microglia) [F(2,18) = 19.85, P < 0.05]. Forty-eight hours after injury both SCI (8.15 ± 0.20% of macrophage/microglia) and SHED groups (7.82 ± 0.36% of macrophage/microglia) showed increased macrophage/microglia numbers in comparison to controls (4.42 ± 0.57% of macrophage/microglia) [F(2,17) = 23.68, P < 0.05]. There was a further increase seventy-two hours after injury, when both injured groups showed an increase of macrophage/microglia in the spinal cord, SCI (11.31 ± 0.98% of macrophage/microglia) and SHED (11.43 ± 0.95% of macrophage/ microglia) [F(2,18) = 18.77, P < 0.05].
As shown in Fig. 4D , there was an increase of T cells measured in the spinal cord only seventy-two hours in the SCI group (7.01 ± 1.81% of T cells) in comparison to control group (2.10 ± 0.31% of T cells) [F(2,18) = 6.58, P < 0.05]. The SHED group remained with normal T cells counts at all times studied, indicating that T cells infiltration was reduced, or blocked, by the SHED transplant.
TNF-a measurement
The expression of TNF-a was measured six, twenty-four, fortyeight and seventy-two hours after lesion to provide one parameter of inflammation process. TNF-a increases in both spinalized groups, SCI (239.50 ± 19.89% of control) and SHED groups (156.80 ± 12.29% of control) six hours after spinal cord injury [F (2,17) = 29.69, P < 0.05] (Fig. 5) . However, SHED group showed a significant reduction of TNF-a level at six hours when compared to SCI group. Two peaks of TNF-a was seen at forty-eight hours, SCI (148.10 ± 11.29% of control) [F(2,16) = 4.94, P < 0.05], as well as at seventy-two hours, SCI (172.20 ± 22.34% of control) [F(2,16) = 6.51, P < 0.05]. SHED group remained at normal levels at fortyeight hours, (128.60 ± 15.97% of control) and showed a significant reduction of TNF-a at seventy-two hours (99.30 ± 23.48% of control) as compared to SCI group, a result similar to that of controls. Therefore, grafted SHED was able to reduce the increase of TNF-a levels following spinal injury.
Neuronal apoptosis
Six hours after injury, double labeled samples with antibodies against MAP-2 and cleaved caspase 3 were subjected to flow cytometry to quantify apoptotic neurons (Fig. 6 ). Flow cytometry took into account all neurons of the samples and data are presented as percentage of neurons in apoptosis process. There was an increase of neuronal apoptosis in the SCI group (2.53 ± 0.46% of neurons) in comparison to control group (0.73 ± 0.13% of neurons). However, the transplant of SHED (1.35 ± 0.14% of neurons) was able to reduce the percentage of apoptotic neurons ( Fig. 6 A- B) [F(2,10) = 6.97, P < 0.05]. These confirm that SHED was able to reduce the early neuronal apoptosis in the spinal cord.
Correlation between anti/pro-apoptotic factors and neuronal apoptosis
Pearson's correlation was run to verify the possible association between apoptotic related factors and neuronal apoptosis. Interestingly, TNF-a levels correlated positively with neuronal apoptosis (r = 0.547, P < 0.05), i.e., the reduction of TNF-a levels is associated with less neuronal apoptosis. Following this line, we evaluated the expression of the anti-apoptotic factor BCL-XL six hours after lesion. BCL-XL was reduced in the SCI group (60.60 ± 10.78% of control) while in SHED group (93.70 ± 7.97% of control) it remained similar to controls ( Fig. 7 A-B) [F(2,10) = 5.21, P < 0.05]. However, no correlation between BCL-XL and neuronal apoptosis was shown (r = -0.457, P > 0.05). Despite SHED transplantation maintained BCL-XL expression similar to controls, it didn't seem to influence neuronal apoptosis. Nevertheless, SHED was able to reduce the increment of TNF-a and to prevent the early neuronal apoptosis in the spinal cord after contusion. 
Expression of EAAT3 and nNOS
The expression of excitatory amino acid transporter 3 (EAAT3) into neurons was assessed by Western Blot. There was an increase of EAAT3 expression in both lesioned groups, SCI group (755.80 ± 155.07% of control) and SHED group (406.50 ± 67.81% of control) measured six hours after injury; however, EAAT3 was significantly lower in the SHED group (Fig. 7C ) when compared to SCI [F(2,10) = 10.82, P < 0.05].
To verify the effects of SHED on the expression of nNOS, Western Blot analysis was run six hours after spinal cord lesion. SCI (203.10 ± 27.73% of control) and SHED groups (149.80 ± 30.22% of control) increased the expression of nNOS. However, SHED presented lower levels in comparison to SCI group (Fig. 7D) , i.e., reduced the overexpression of nNOS (F (2,10) = 13.64, P < 0.05). Interestingly, this increase in nNOS expression was negatively correlated with that mitochondrial membrane protein BCL-XL expression (r = -0.646, P < 0.05) and also correlated positively with neuronal apoptosis (r = 0.600, P < 0.05). These indicate an association between the expression of nNOS, the damage of mitochondrial membrane and neuronal apoptosis. Furthermore, a positive correlation was found between EAAT3 expression and nNOS expression (r = 0.620, P < 0.05). 
Discussion
Data presented confirms that human dental pulp stem cells transplantation promotes functional recovery and tissue protection after spinal cord contusion. For the first time, the effects of SHED transplant were assessed in the acute phase of spinal cord injury, starting just six hours after the injury. Results demonstrated that SHED protected neurons against early loss and favored greater motor neurons survival in the ventral horn of spinal cord that lasted for the whole experiment, i.e., six week post lesion. SHED transplantation acted on a variety of mechanisms: reducing astrocytes hyperplasia, T cells entrance and expression of pro-apoptotic factor (TNF-a), as well as keeping the mitochondrial constitutive protein (BCL-XL) at normal levels in spinal tissue. Additionally, SHED transplantation prevented the overexpression of neuronal excitatory amino acid transporter 3 (EAAT3) and of neuronal nitric oxide synthase (nNOS). Probably the integration and the prolonged survival of SHED into spinal cord parenchyma (Nicola et al., 2016; Sakai et al., 2012; Taghipour et al., 2012) contributed to these short and long term effects.
SCI caused functional deficits assessed by the BBB scale (Fig. 2) , as expected from the second day after lesion (Basso et al., 1995; Rodrigues et al., 2012; Sakai et al., 2012) . The functional recovery promoted by SHED transplantation (de Almeida et al., 2011; Nicola et al., 2016) was confirmed, as depicted in Fig. 2 ; SHED rats performed better hindlimbs movements than SCI animals from the first week, an improvement that remained significant until the sixth week. The early benefit on functional recovery confirms the potential of SHED transplantation and suggests a neuroprotective effect (Nicola et al., 2016; Sakai et al., 2012; Taghipour et al., 2012) . This hypothesis is reinforced by tissue and neuronal cells preservation.
The functional recovery promoted by SHED treatment can be explained by tissue preservation in the spinal cord six weeks after injury (Fig. 3 A-C) , since functional deficits tend to be proportional to the lesion severity, that is, tissue loss causes functional impairment (Basso et al., 1996) and tissue protection promotes functional recovery. Having confirmed tissue preservation, the next step was to evaluate the number of motor neurons in the ventral horn of the spinal cord. Interestingly, the SHED transplantation was able to reduce motor neuron loss, showing a higher number of these cells than SCI group six weeks after lesion (Fig. 3 D-E) ; furthermore, the number of motor neurons presented a strong positive correlation with the last-day BBB scores, suggesting that hind limb locomotor ability depends on the survival of motor neurons below the lesion site.
Considering the early functional recovery, already present seven days after contusion, and the higher number of motor neurons in the anterior horn of spinal cord in the treated group, putative mechanisms of the neuroprotection promoted by SHED were investigated (Nicola et al., 2016; Sakai et al., 2012; Taghipour et al., 2012) . Firstly, flow cytometry was used to verify the progression and the critical time point where the neuronal loss was occurring. Neuronal loss was shown to be progressive, as previously reported (Casella et al., 2006) and stabilized forty-eight hours after lesion. SHED transplantation was able to reduce such prolonged neuronal loss and stabilized twenty-four hours, earlier than expected. The basal number of neurons is in accordance with previous report (Burish et al., 2010) . Additionally, flow cytometry of astrocytes, macrophages/ microglia and T cells was run to verify whether the presence of these cells would be related to neuronal loss in the spinal cord.
Astrocytes, like neurons, die in the acute phase after spinal cord lesion (Casella et al., 2006) and we demonstrated that SHED did not interfere in the early loss of astrocyte cells. The reduction of astrocytes in the spinal cord remained until twenty-four hours; from that time on there was astrocytic proliferation with a peak at seventy-two hours after lesion, interpreted as hyperplasia (Burda and Sofroniew, 2014) . Such proliferation and astrocyte hypertrophy are considered a typical response of the neural tissue to injury that may be intrinsically linked to glial scar formation (Ridet et al., 1997; Sofroniew, 2009) . SHED group showed an increase of astrocytes until seventy-two hours where remained equal to control group and different from SCI group, i.e., SHED showed a reduction of the astrocyte proliferation relative to that of SCI group at seventy-two hours. It is important to note that the increment of astrocyte cells occurred seventy-two hours after SCI and probably did not interfere with neuronal death, which was complete twenty-four hours after lesion.
The immune response mediated by macrophages/microglia plays an important role in the secondary spinal cord damage by cell phagocytosis and release of cytokines (David and Kroner, 2011) . There is an increase in the number of macrophages/microglia in spinal tissue as evidenced by flow cytometry (Beck et al., 2010) . Macrophages/microglia numbers increased progressively in both injured groups, an effect not influenced by SHED transplantation, what corroborated with a previous report (Matsubara et al., 2015) . It is known that T cells, peripheral immune cells, infiltrate the injured tissue (Benjelloun et al., 1999 ) and contribute to cell death at the lesion site by enhancing the inflammatory process (Fathali et al., 2013) . Although SHED transplant did not reduce the number of macrophages/microglia, they were able to inhibit the entry of T cells into the spinal parenchyma seventy-two hours post-injury. It is suggested that SHED may be inhibiting chemokine signals that recruit T cells (Jones et al., 2005) ; further studies are needed to clarify this point.
Pro-inflammatory cytokine TNF-a was assessed in the spinal cord to evaluate if the presence of immune cells in spinal tissue altered the inflammatory responses. The spinal cord showed an overexpression of TNF-a at six hours after lesion, which was reduced by SHED transplantation (Fig. 5) , a known effect of mesenchymal stem cells (Nakajima et al., 2012) . Although both SCI and SHED groups showed increased numbers of macrophages/ microglia, TNF-a levels remained high until seventy-two hours only in the SCI group; SHED transplantation stabilized TNF-a levels as early as twenty-four hours after lesion. Matsubara and colleagues (2015) described that SHED has the ability to modulate macrophages/microglia function, being able to modify the phenotype of these cells from pro-inflammatory to the antiinflammatory phenotype (Matsubara et al., 2015) .
Apoptosis has been consistently reported as one of the most important mechanisms of cell death after spinal cord injury (Crowe et al., 1997; Emery et al., 1998; Grossman et al., 2001; Liu et al., 1997; Lou et al., 1998; Ríos et al., 2015) . Here, neuronal apoptosis was measured by flow cytometry from double labeling against MAP-2 (a neuronal marker) and cleaved caspase 3 (to mark cells undergoing an apoptotic process) six hours after SCI. Caspase 3 is recognized as a starter molecule of the apoptotic pathway (Elmore, 2007) and its expression is widely used to verify apoptosis after SCI (Emery et al., 1998; Ríos et al., 2015) . The SHED group presented a smaller number of apoptotic neurons than the SCI group, and this phenomenon probably contributed to the survival of the motor neurons observed in the histology analysis six weeks after SCI (Fig. 3 D-E) . To our knowledge, this is the first description of an anti-apoptotic effect of transplanted SHED in this model of spinal cord contusion injury (Fig. 6) .
The mechanisms of apoptosis are complex and involve an energy-dependent cascade of molecular events. There are two main apoptotic pathways: the extrinsic, or death receptor pathway, activated by TNF-a; and the intrinsic or mitochondrial pathway that depends on this organelle membrane integrity (Elmore, 2007) . The increase of TNF-a levels after spinal cord contusion activate the death receptor in the outside of the cellular membrane, which starts the cleavage of caspases and leads to apoptosis (Elmore, 2007; Qiu et al., 2001) . At the same time, spinal cord injury decreases the expression of mitochondrial BCL-XL that is a constitutive membrane protein of this organelle (Elmore, 2007; Qiu et al., 2001; Yune et al., 2003) . This mitochondrial damage results in loss of mitochondrial function, which releases proapoptotic factors, including cytochrome c (Holohan et al., 2008) . In the cytosol, cytochrome c triggers caspase cleavage resulting in apoptosis (Elmore, 2007) . Here, SHED kept the BCL-XL levels six hours after SCI (Fig. 7 A-B) , probably preventing mitochondrial-mediated apoptosis by maintaining the membrane integrity (Green and Reed, 1998; Holohan et al., 2008; Sawatzky et al., 2006) . The maintenance of BCL-XL and the inhibition of overexpression of TNF-a promoted by SHED transplantation probably contributed to decreasing neuronal apoptosis in the spinal cord. However, other mechanisms associated with neuronal death may be subjected to SHED modulation.
Excitotoxic events leading to calcium influx through NMDA receptors as well as inflammatory cytokines, such as TNF-a, may induce apoptosis through the activation of neuronal nitric oxide synthase (nNOS) (Anwar et al., 2016; Blomgren et al., 2007; Holohan et al., 2008) , that increases the nitric oxide levels and may result in irreversible damage to mitochondria membrane (Blomgren et al., 2007) . Here the expression of nNOS and EAAT3, the excitatory amino acid transporter 3 related to removal of glutamate from the extracellular space were studied. SHED reduced the overexpression of nNOS in the spinal cord what could be favoring the oxide nitric homeostasis (Fig. 7 A, D) . Additionally, there was a positive correlation of neuronal apoptosis, nNOS expression and TNF-a levels, that is, the increase of nNOS or/and TNF-a produced greater neuronal apoptosis, reinforcing the idea of an interaction between these two factors and neuronal death. Besides, the increase of excitatory amino acid transporter 3 (EAAT3) in the SCI group can be interpreted as an increased need to capture extracellular glutamate (Fig. 7 A, C) ; SHED inhibited the EAAT3 overexpression. However, further studies will be needed to shed light on this. The fact is that SHED transplantation one hour after spinal cord injury was capable to reduce the increase of TNF-a, EAAT3 and nNOS expression and it may have contributed to reducing neuronal apoptosis.
Summarizing, the acute transplantation of SHED promoted functional recovery, tissue preservation and long-term motor neuron survival. The neuronal loss occurred progressively after the injury, and the early intervention was crucial to increase neuronal survival in the injured spinal cord. Acute transplantation of SHED modulated a variety of events, contributing to the early reduction in the neuronal loss by apoptosis, promoting a greater number of neurons as from forty-eight hours. Probably the reduction of TNF-a increase, and the overexpression of EAAT3 and of nNOS, with BCL-XL at normal levels contributed to lower neuronal apoptosis. The understanding of mechanisms related to functional recovery caused by SHED transplantation can contribute to the development of new treatment strategies and/or definition of new therapeutic windows for spinal cord contusion.
Experimental procedure
Isolation and culture of SHED
Stem cells from human exfoliated deciduous teeth (SHED) were collected, isolated and cultured following the protocol of Bernardi and colleagues (Bernardi et al., 2011) . The donor gave written informed consent to participate in the study, which was approved by the Ethics Committee of the Universidade Federal do Rio Grande do Sul (#296/08).
Dental pulp was removed and incubated at 37°C for 60 min in buffer containing 0.2% type 1 colagenase (Gibco, USA). Dental pulp cells were removed from the dental parenchyma and cultivated as previously described (Luisi et al., 2007) . All pulp tissue was removed (crown and root) from the dentin and the resulting cell suspension was seeded onto a 12-well plate. The culture medium DMEM (Dulbecco's), supplemented with 10% fetal bovine serum (Laborclin, Brazil), was changed 24 h after the initial plating and every 3 or 4 days, thereafter. When 90% confluence was reached, a passage using trypsin-EDTA 0.5% (Sigma-Aldrich, USA) was performed to loosen the cells from the plate. The density seeded cells in each passage was 10 4 cells/cm 2 . Cells of the 5th passage were utilized for cell transplantation and for culture characterization analysis.
Characterization of SHED by flow cytometry
10
6 cells from cultivated human exfoliated teeth in the 5th passage (n = 3) were incubated with the following conjugated antibodies against human cell surface molecules: CD29, CD34 (hematopoietic stem/progenitor cells/endothelium), CD44, CD45, CD73, CD90 (common leukocyte antigens), HLA-DR (human leukocyte antigen, class II), CD14 (monocyte/macrophage), CD184 and STRO-1 (Stromal Cell Surface Marker) (PharMingen-BD Biosciences, USA), conjugated with FITC (Santacruz, USA) or PE (PharMingen-BD Biosciences, USA). Data acquisition was performed using the FACSAria III flow cytometer (BD Biosciences, USA) and 10,000 events were analyzed using FACS Diva 6.1.3 software (BD Biosciences, USA) (Bernardi et al., 2011) .
Experimental design
Male Wistar rats aged 2 months (200-250 g body weight) were obtained from the Animal House of the Instituto de Ciências Bási-cas da Saúde of the Universidade Federal do Rio Grande do Sul. They were maintained in a temperature-controlled room (21 ± 2°C) on a 12/12 h light/dark cycle, with food and water available ad libitum. All procedures were in accordance with the Guide for the Care and Use of Laboratory Animals adopted by the National Institute of Health (USA) and with the Federation of Brazilian Societies for Experimental Biology. The study was approved by the Research Ethics Committee of the University (#26116). The animals were randomly divided into four experimental groups: Naive (without any manipulation) or Surgical control, Sham (laminectomy with no SCI); SCI (laminectomy followed by SCI, treated with vehicle); SHEDs (SCI treated with SHEDs). Three experiments were run: 1) functional long-term assessment of animals was run 2 days after SCI and weekly until the seventh week; at the end of the experiment samples were processed for histological analysis to estimate the cystic cavity volume and the presence of motor neurons in the ventral horn of spinal cord (n = 8-9 per group); 2) six, twenty-four, forty-eight and seventy-two hours after contusion, flow cytometry analysis was run to quantify neurons, astrocytes, macrophages/microglia and T cells in the spinal cord; a proinflammatory cytokine (TNF-a) was measured by ELISA at the same time points to show a parameter of inflammation over time in the spinal cord (n = 7 per group); 3) for the short-term, apoptotic neurons were quantified by flow cytometry and some key proteins related to cell death were measured by Western Blot six hours after SCI (n = 5-6 per group). For the first experiment, Sham animals were used as controls; in the second and in the third experiments Naive animals were used as controls, aiming to reduce the number of experimental animals. There was a 10% death rate after the surgical procedure. Animal care was in accordance with the Multicen-ter Animal Spinal Cord Injury Study (MASCIS) protocols (Weeks and Hart, 2004) . The experimental design is depicted in Fig. 1. 
Spinal cord injury and SHED transplant
The animals were previously anesthetized with a mixture of xylasine (100-150 mg/kg) and ketamine (60-90 mg/kg). Laminectomy was performed at the level of 9th thoracic vertebra (T9) and injury was induced through the drop of a 10 g weight from 25 mm height by the use of New York University Impactor device (NYU-Impactor Ò ; W.M. Keck Center for Collaborative Neuroscience, USA) (Park et al., 2013) . The SHED group received the administration of 3 Â 10 5 cells diluted in 0.9% NaCl. 10-mL of cell suspension injected at the lesion site 1 h after the injury with a 25-mL sterile Hamilton syringe, and carried out without immunosuppression (Xavier Acasigua et al., 2014) . Animals were sutured following the surgical procedure and housed in individual cages; bladder evacuation was performed daily until function was restored. Antibiotic (Enrofloxacino, Bayer, Brazil; 6 mg/kg) was administered for 7 days after the procedure to prevent infection.
Locomotor activity assessment
Behavior was recorded in an open field and following this, the motor function of the hind limbs was evaluated using the Basso, Beatie, and Bresnahan scale (BBB), which assesses hind limb motor function with scores ranging from 0 (complete paralysis) to 21 (normal locomotion) (Basso et al., 1995) . Evaluation began 2 days before injury or laminectomy (in the Sham group) and was repeated 2 days after, and then weekly until the sixth week after SCI. A video recording was observed for scale scoring by two examiners who were blind to the animal's treatments (Basso et al., 1995) .
Morphologic analysis
Animals were anesthetized with pentobarbital (100 mg/kg, i.p.; Cristália, Brazil) followed by transcardiac perfusion with 0.9% saline followed by 4% paraformaldehyde (Reagen, Brazil) in 0.1 M phosphate buffer (PBS, pH 7.4). The spinal cord was removed from C5 to L5 in the thoracic region, post-fixed in the same fixative solution and cryoprotected with 15% and 30% sucrose diluted in phosphate buffer saline (PBS). After cryoprotection, the samples were frozen in isopentane and cooled in liquid nitrogen until slicing (Rodrigues et al., 2012) . For histological and immunohistochemistry analysis, the thoracic region of the spinal cord was transversally cut into 20 mm sections in cryostat (Leica, Germany). The sections were stained with hematoxylin and eosin and the images were captured using a Nikon Eclipse E-600 microscope (Japan) coupled with a digital camera.
Thirty transversal 20 mm sections from each animal were processed to estimate the cavitation area and the number of motor neurons. Sequential sections with an interval of 300 mm were collected. The cavitation area in each sequential slice was determined and the largest cavitation area slice (called the epicenter) of each rat was determined. The cavitation area was estimated using the software Image J v. 1.46 (http://rsbweb.nih.gov/ij/); any necrotic tissue within the cavities was considered as part of the lesion and the total sum of areas was measured. Six sequential slices below the lesion epicenter were used to assess the number of motor neurons in the ventral horn of the spinal cord.
Flow cytometry analysis
The spinal cords were dissociated with Trypsin/PBS (0,006 g/ mL) (Sigma-Aldrich -T2600000) and the cells were then permeabilized with 0.1% PBS Triton X-100 for 10 min at room temperature, blocked for 15 min with 3% normal goat serum (SigmaAldrich -G9023). After blocking, the cells were incubated with primary antibodies, against neuron MAP-2 (Mouse,Sigma Aldrich -M4403), against astrocyte GFAP (Rabbit, Sigma Aldrich -G4546 or Mouse, G3893,Sigma Aldrich), against macrophage/microglia CD11b (Mouse, Millipore -CBL1512), against T cells CD3 (Rabbit, Sigma Aldrich -C7930). For neuronal apoptosis the cells were double labeled with MAP-2 (Mouse,Sigma Aldrich -M4403) and Cleaved caspase 3 (Rabbit, Cell Signalling -#9661), an apoptosis cell marker at final concentration of 1:100 at room temperature for 2 h. The cells were washed twice with PBS and incubated for 1 h with IgG antibody Alexa-fluor 633 anti-rabbit and IgG antibody Alexa-fluor 488 anti-mouse, at a final concentration of 1:200. Negative controls (samples with the secondary antibody) were included for setting up the machine voltages and to determine the negative region of dot plot. The emission of fluorochromes was recorded through a specific band-pass fluorescence filter: red (FL-4; 670 nm long pass) or green (FL-1; 488 nm long pass). Fluorescence emissions were collected using logarithmic amplification. Data from 10,000 events (intact cells) were acquired and the number of cells was determined after exclusion of debris events from the data set. The number of cells in each quadrant was computed and cells stained separately was expressed as the percentage of positive immune labeled cells (Heimfarth et al., 2013) . All flow cytometric acquisitions and analyses were performed using FACSCalibur (Becton Dickinson, Franklin Lakes, NJ, USA) and Flow Jo software v10.1 (Weis et al., 2012) .
Quantification of TNF-alpha
TNF-a concentration in the spinal cord tissue was measured by using TNF-a ELISA kit (eBioscience, Ref. 88-7340, San Diego, USA), according to the manufacturer's protocol.
Western blotting
Tissue was homogenized in ice-cold lysis buffer (10 mM KCl, 150 mM NaCl, 10 mM Hepes, 0.6 mM EDTA, 1% NP 40, 1% Triton-X, 1% sodium deoxycholate, 1% glycerol, and 1% protease inhibitor cocktail) pH 7.9, and centrifuged at 1000g for 30 min. Equal protein concentrations (40 lg/lane of total protein, determined using a commercial kit BCA Protein Assay [Thermo Scientific, U.S.A]) were loaded onto NuPAGE Ò 4-12% Bis-Tris Gels. and subsequently transferred (XCell SureLock Ò Mini-Cell, Invitrogen) to nitrocellulose membranes for 1 h in transfer buffer (48 mM Trizma, 39 mM glycine, 20% methanol, and 0.25% SDS]) (Arcego et al., 2016) . The blot was incubated 2 h in blocking solution [Tris-buffered saline (TBS; 0.14 M NaCl, 2.4 mM Trizma, pH 7.7) plus 5% bovine serum albumin], followed by incubation overnight at 4°C in a blocking solution containing one of the following antibodies,, at a final dilution of 1:1000: anti-BCL-XL (Rabbit, Cell Signaling -#2762), anti-EAAT3 (Mouse, Millipore -MAB1587), anti-nNOS (Rabbit, Cell Signaling -#4234) and anti-b-actin (Rabbit, Cell Signaling -#4967). The blot was then washed three times for 5 min with Tween-TBS and incubated for 2 h in solution containing peroxidase-conjugated anti-rabbit IgG (GE Life Sciences -RPN4301) or anti-mouse IgG (Millipore -402335) diluted 1:1000. The blot was washed again three times for 10 min with Tween-TBS and once for 10 min with TBS. The signal was detected using a chemiluminescence ECL Kit (GE Life Sciences -RPN2109).
Immunoblots were quantified by scanning the membranes in ImageQuant LAS4000 (GE Healthcare Life Sciences -United Kingdom) and determining optical densities through Image Studio Lite V5.0 (LI-COR Biosciences -US). Results were expressed as the ratio of intensity of the protein of interest to that of anti-b-actin from the same membrane.
Statistical analysis
Data are presented as mean ± standard error of the mean (SEM). One-way ANOVA was used to analyze quantitative data, followed by Duncan post hoc test to reveal differences between the groups whenever indicated. Correlation coefficients (r) were calculated by Pearson's correlation. Significance was assumed at P < 0.05. All analyses were carried out using IBM SPSS Statistics software v.19.
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